Suppr超能文献

突变型 p53 通过上皮-间充质转化破坏 MCF-10A 细胞在三维培养中的极性。

Mutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitions.

机构信息

Comparative Oncology Laboratory, University of California, Davis, California 95616, USA.

出版信息

J Biol Chem. 2011 May 6;286(18):16218-28. doi: 10.1074/jbc.M110.214585. Epub 2011 Mar 22.

Abstract

Mutant p53 is not only deficient in tumor suppression but also acquires additional activity, called gain of function. Mutant p53 gain of function is recapitulated in knock-in mice that carry one null allele and one mutant allele of the p53 gene. These knock-in mice develop aggressive tumors compared with p53-null mice. Recently, we and others showed that tumor cells carrying a mutant p53 are addicted to the mutant for cell survival and resistance to DNA damage. To further define mutant p53 gain of function, we used the MCF-10A three-dimensional model of mammary morphogenesis. MCF-10A cells in three-dimensional culture undergo a series of morphological changes and form polarized and growth-arrested spheroids with hollow lumen, which resembles normal glandular architectures in vivo. Here, we found that endogenous wild-type p53 in MCF-10A cells was not required for acinus formation, but knockdown of endogenous wild-type p53 (p53-KD) led to partial clearance of cells in the lumen due to decreased apoptosis. Consistent with this, p53-KD altered expression patterns of the cell adhesion molecule E-cadherin, the cytoskeletal marker β-catenin, and the extracellular matrix protein laminin V. We also found that ectopic expression of the mutant G245S led to a phenotype similar to p53-KD, whereas a combination of ectopic expression of siRNA-resistant G245S with p53-KD led to a less cleared lumen. In contrast, ectopic expression of mutant R248W, R175H, and R273H disrupted normal acinus architectures with filled lumen and led to formation of irregular and multiacinus structures regardless of p53-KD. In addition, these mutants altered normal expression patterns and/or levels of E-cadherin, β-catenin, laminin V, and tight junction marker ZO-1. Furthermore, epithelial-to-mesenchymal transitions (EMT) markers, Snail, Slug, and Twist, were highly induced by mutant p53 and/or p53-KD. Together, we postulate that EMT represents a mutant p53 gain of function and mutant p53 alters cell polarity via EMT.

摘要

突变型 p53 不仅缺乏肿瘤抑制作用,而且还获得了另外一种被称为获得性功能的活性。在携带一个 p53 基因的无效等位基因和一个突变等位基因的敲入小鼠中,可重现突变型 p53 的获得性功能。与 p53 缺失型小鼠相比,这些敲入小鼠发展出侵袭性肿瘤。最近,我们和其他人表明,携带突变型 p53 的肿瘤细胞对突变型 p53 产生了依赖性,以维持细胞存活并抵抗 DNA 损伤。为了进一步定义突变型 p53 的获得性功能,我们使用了 MCF-10A 三维乳腺形态发生模型。在三维培养中,MCF-10A 细胞经历一系列形态变化,并形成具有中空腔的极化和生长停滞的球体,类似于体内正常的腺结构。在这里,我们发现 MCF-10A 细胞中的内源性野生型 p53 对于小泡形成不是必需的,但是内源性野生型 p53(p53-KD)的敲低导致由于凋亡减少而导致腔中的细胞部分清除。与此一致,p53-KD 改变了细胞粘附分子 E-钙粘蛋白、细胞骨架标记物β-连环蛋白和细胞外基质蛋白层粘连蛋白 V 的表达模式。我们还发现,突变型 G245S 的异位表达导致类似于 p53-KD 的表型,而 siRNA 抗性 G245S 的异位表达与 p53-KD 的组合导致腔的清除程度降低。相比之下,突变型 R248W、R175H 和 R273H 的异位表达导致充满腔的正常小泡结构被破坏,并导致形成不规则的多小泡结构,而与 p53-KD 无关。此外,这些突变体改变了正常的 E-钙粘蛋白、β-连环蛋白、层粘连蛋白 V 和紧密连接标记物 ZO-1 的表达模式和/或水平。此外,上皮-间充质转化(EMT)标志物 Snail、Slug 和 Twist 被突变型 p53 和/或 p53-KD 高度诱导。总的来说,我们假设 EMT 代表突变型 p53 的获得性功能,并且突变型 p53 通过 EMT 改变细胞极性。

相似文献

1
Mutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitions.
J Biol Chem. 2011 May 6;286(18):16218-28. doi: 10.1074/jbc.M110.214585. Epub 2011 Mar 22.
2
Mutant p53 cooperates with knockdown of endogenous wild-type p53 to disrupt tubulogenesis in Madin-Darby canine kidney cells.
PLoS One. 2013 Dec 27;8(12):e85624. doi: 10.1371/journal.pone.0085624. eCollection 2013.
3
Mammary epithelial cell polarity is regulated differentially by p73 isoforms via epithelial-to-mesenchymal transition.
J Biol Chem. 2012 May 18;287(21):17746-17753. doi: 10.1074/jbc.M112.358143. Epub 2012 Mar 28.
4
The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation.
J Cell Sci. 2004 Apr 1;117(Pt 9):1675-85. doi: 10.1242/jcs.01004. Epub 2004 Mar 9.
5
GSK3, snail, and adhesion molecule regulation by cyclosporine A in renal tubular cells.
Toxicol Sci. 2012 Jun;127(2):425-37. doi: 10.1093/toxsci/kfs108. Epub 2012 Mar 12.
7
Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells.
Cell Death Differ. 2011 Feb;18(2):271-81. doi: 10.1038/cdd.2010.94. Epub 2010 Aug 6.
9
Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
J Cell Sci. 2010 Apr 15;123(Pt 8):1295-305. doi: 10.1242/jcs.061002. Epub 2010 Mar 23.

引用本文的文献

3
Convergent TP53 loss and evolvability in cancer.
BMC Ecol Evol. 2023 Sep 25;23(1):54. doi: 10.1186/s12862-023-02146-6.
5
Evolutionary determinants of curability in cancer.
Nat Ecol Evol. 2023 Nov;7(11):1761-1770. doi: 10.1038/s41559-023-02159-w. Epub 2023 Aug 24.
7
The Many Microenvironments of Ovarian Cancer.
Adv Exp Med Biol. 2020;1296:199-213. doi: 10.1007/978-3-030-59038-3_12.
8
Epithelial p53 Status Modifies Stromal-Epithelial Interactions During Basal-Like Breast Carcinogenesis.
J Mammary Gland Biol Neoplasia. 2021 Jun;26(2):89-99. doi: 10.1007/s10911-020-09477-w. Epub 2021 Jan 13.
9
AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling.
Mol Cancer Res. 2021 Apr;19(4):573-584. doi: 10.1158/1541-7786.MCR-20-0623. Epub 2020 Dec 10.

本文引用的文献

1
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.
Nat Cell Biol. 2011 Mar;13(3):317-23. doi: 10.1038/ncb2173. Epub 2011 Feb 20.
2
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells.
J Exp Med. 2010 Sep 27;207(10):2127-40. doi: 10.1084/jem.20100797. Epub 2010 Aug 9.
3
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.
Oncogene. 2010 Aug 26;29(34):4741-51. doi: 10.1038/onc.2010.215. Epub 2010 Jun 7.
4
Cell polarity in eggs and epithelia: parallels and diversity.
Cell. 2010 May 28;141(5):757-74. doi: 10.1016/j.cell.2010.05.011.
5
Characterization of functional domains necessary for mutant p53 gain of function.
J Biol Chem. 2010 May 7;285(19):14229-38. doi: 10.1074/jbc.M109.097253. Epub 2010 Mar 8.
6
Mutant p53 drives invasion by promoting integrin recycling.
Cell. 2009 Dec 24;139(7):1327-41. doi: 10.1016/j.cell.2009.11.026.
7
Polarity proteins regulate mammalian cell-cell junctions and cancer pathogenesis.
Curr Opin Cell Biol. 2009 Oct;21(5):694-700. doi: 10.1016/j.ceb.2009.07.003. Epub 2009 Sep 2.
8
When mutants gain new powers: news from the mutant p53 field.
Nat Rev Cancer. 2009 Oct;9(10):701-13. doi: 10.1038/nrc2693. Epub 2009 Aug 20.
9
Biomarkers for epithelial-mesenchymal transitions.
J Clin Invest. 2009 Jun;119(6):1429-37. doi: 10.1172/JCI36183. Epub 2009 Jun 1.
10
Identification of GRO1 as a critical determinant for mutant p53 gain of function.
J Biol Chem. 2009 May 1;284(18):12178-87. doi: 10.1074/jbc.M900994200. Epub 2009 Mar 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验